The Wall Street Transcript

Samuel Beall Iii – Ruby Tuesday Inc (ri)

SAMUEL E. 'SANDY' BEALL, III, is Chairman and Chief Executive Officer of Ruby Tuesday, Inc. The company is listed on the New York Stock Exchange and has over 550 company-owned and operated and ...
London South East

Positive phase III RUBY results for Jemperli

· Results presented in same-day presentations at ESMO Virtual Plenary and SGO Annual Meeting and simultaneously published in The New England Journal of Medicine · Regulatory submissions planned for ...
Seeking Alpha

Phase III RUBY clinical trial demonstrates potential of Jemperli (dostarlimab-gxly) plus chemotherapy to redefine the treatment of primary advanced or recurrent endometrial ...

72% and 36% reduction in the risk of disease progression or death observed in the dMMR/MSI-H population and overall patient population, respectively Clinically meaningful overall survival trend ...
Pharmabiz

GSK announces phase III RUBY trial demonstrates potential of Jemperli plus chemotherapy to redefine the treatment of primary advanced or recurrent endometrial cancer versus ...

GSK plc announced interim results from Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial investigating Jemperli (dostarlimab) plus standard-of-care ...